233 related articles for article (PubMed ID: 22713657)
1. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer.
Jiang X; Hiki N; Nunobe S; Kumagai K; Kubota T; Aikou S; Sano T; Yamaguchi T
Br J Cancer; 2012 Jul; 107(2):275-9. PubMed ID: 22713657
[TBL] [Abstract][Full Text] [Related]
2. The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9.
Zhang S; Li JZ; Du T; Li HQ; Hu RH; Ma CY; Cui XM; Song C; Jiang XH
Can J Gastroenterol Hepatol; 2022; 2022():3953004. PubMed ID: 35734015
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.
Inoue Y; Iwata T; Okugawa Y; Kawamoto A; Hiro J; Toiyama Y; Tanaka K; Uchida K; Mohri Y; Miki C; Kusunoki M
Oncology; 2013; 84(2):100-7. PubMed ID: 23147449
[TBL] [Abstract][Full Text] [Related]
4. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Kubota K
Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer.
Hirashima K; Watanabe M; Shigaki H; Imamura Y; Ida S; Iwatsuki M; Ishimoto T; Iwagami S; Baba Y; Baba H
J Gastroenterol; 2014 Jun; 49(6):1040-6. PubMed ID: 23821018
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Systemic Inflammation on Treatment Response and Survival in Anal Squamous Cell Cancer.
Knight K; Choong JX; McKee RF; Anderson JH; Horgan PG; McMillan DC; McDonald A; Roxburgh CS
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e22-e30. PubMed ID: 32709540
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Horie T; Kubota K
Ann Surg; 2007 Dec; 246(6):1047-51. PubMed ID: 18043109
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of an inflammation-based prognostic system for gastric cancer patients with a preoperative normal serum level of carcinoembryonic antigen.
Ishizuka M; Oyama Y; Abe A; Tago K; Tanaka G; Kubota K
Anticancer Res; 2014 Dec; 34(12):7219-26. PubMed ID: 25503152
[TBL] [Abstract][Full Text] [Related]
10. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer.
Takeno S; Hashimoto T; Shibata R; Maki K; Shiwaku H; Yamana I; Yamashita R; Yamashita Y
Oncology; 2014; 87(4):205-14. PubMed ID: 25034097
[TBL] [Abstract][Full Text] [Related]
11. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
[No Abstract] [Full Text] [Related]
12. Utility of Inflammatory Marker- and Nutritional Status-based Prognostic Factors for Predicting the Prognosis of Stage IV Gastric Cancer Patients Undergoing Non-curative Surgery.
Mimatsu K; Fukino N; Ogasawara Y; Saino Y; Oida T
Anticancer Res; 2017 Aug; 37(8):4215-4222. PubMed ID: 28739709
[TBL] [Abstract][Full Text] [Related]
13. The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases.
Nakagawa K; Tanaka K; Nojiri K; Kumamoto T; Takeda K; Ueda M; Endo I
Ann Surg Oncol; 2014 May; 21(5):1711-8. PubMed ID: 24452408
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.
Jeong JH; Lim SM; Yun JY; Rhee GW; Lim JY; Cho JY; Kim YR
Oncology; 2012; 83(5):292-9. PubMed ID: 22964877
[TBL] [Abstract][Full Text] [Related]
16. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
[TBL] [Abstract][Full Text] [Related]
17. The value of the systematic inflammation-based Glasgow Prognostic Score in patients with gastric cancer: a literature review.
Gao Y; Huang D
J Cancer Res Ther; 2014; 10(4):799-804. PubMed ID: 25579511
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer.
Dutta S; Crumley AB; Fullarton GM; Horgan PG; McMillan DC
Am J Surg; 2012 Sep; 204(3):294-9. PubMed ID: 22444831
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
20. Inflammation-based prognostic system predicts postoperative survival of esophageal carcinoma patients with normal preoperative serum carcinoembryonic antigen and squamous cell carcinoma antigen levels.
Ma Q; Liu W; Jia R; Jiang F; Duan H; Lin P; Zhang L; Long H; Zhao H; Ma G
World J Surg Oncol; 2016 May; 14():141. PubMed ID: 27151090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]